Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.9K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

133
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
133
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

405
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
405
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Augmenting Medical Judgment in Signal Confirmation: Design Considerations for an AI-Enabled Causality Assessment Framework.

Drug safety·2026
Same author

Accelerating scientific discovery with Co-Scientist.

ArXiv·2026
Same author

Safety steps: A framework for promoting safe trainee autonomy in clinical emergencies.

Journal of hospital medicine·2026
Same author

Towards Conversational AI for Disease Management.

Nature·2026
Same author

Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence.

Drug safety·2026
Same author

Accelerating scientific discovery with Co-Scientist.

Nature·2026

Related Experiment Video

Updated: Sep 23, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

604

Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.

Benjamin Kompa1,2, Joe B Hakim3, Anil Palepu3

  • 1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Drug Safety
|May 17, 2022
PubMed
Summary

This review examines how machine learning is being used to monitor drug safety. While many studies still rely on older statistical methods, newer approaches like deep learning are becoming more common. The authors highlight a need for better adherence to best practices in the field.

Keywords:
drug safetydeep learningclinical informaticssignal detection

Frequently Asked Questions

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.7K

Related Experiment Videos

Last Updated: Sep 23, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

604
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.7K

Area of Science:

  • Pharmacovigilance research within clinical pharmacology
  • Artificial intelligence applications in health informatics

Background:

The integration of advanced computational tools into drug safety monitoring remains poorly defined. Prior research has shown that automated systems transform various medical sectors. That uncertainty drove a need to evaluate current progress in this specific domain. No prior work had resolved the extent of modern algorithmic adoption. This gap motivated a comprehensive assessment of existing literature. Investigators sought to clarify how these digital innovations influence safety reporting. Previous efforts often lacked a systematic overview of diverse methodological approaches. Researchers required a clear synthesis to understand the current landscape of safety surveillance.

Purpose Of The Study:

The aim of this work is to evaluate the application of automated computational tools within drug safety monitoring. Researchers sought to understand how these technologies are currently utilized for surveillance tasks. The team wanted to characterize how these efforts differ from other scientific domains. They also intended to identify specific opportunities for improving safety reporting through advanced modeling. This study addresses the need for a systematic overview of existing literature. The authors focused on identifying which methodologies show the most promise for future implementation. They aimed to provide a clear picture of how modern algorithms influence safety workflows. This investigation serves to bridge the gap between technical potential and practical application in the field.

Main Methods:

The review approach involved searching four major databases for relevant publications. Investigators queried PubMed, Embase, Web of Science, and IEEE Xplore. The search covered articles published between the year 2000 and September 2021. Experts performed a manual screening of over seven thousand initial abstracts. A final set of three hundred ninety-three papers met the inclusion criteria. The team extracted specific details regarding study design and sample size. They also documented the technical methodologies employed in each selected work. Finally, the group evaluated whether these papers adhered to established quality standards.

Main Results:

Key findings from the literature reveal that fifty-three percent of papers rely on traditional statistical approaches for signal detection. Among studies utilizing modern algorithms, sixty-one percent employ off-the-shelf techniques with minimal changes. The analysis shows that only forty-two papers, representing ten percent of the total, follow current best practices. Regarding data intake, thirty out of one hundred fifty-four studies successfully incorporated these rigorous standards. Temporal trends indicate that deep learning methods are seeing increased usage in recent years. The data demonstrate that widespread adoption of advanced computational tools remains limited. Most research currently lacks the depth required for optimal safety monitoring. These results quantify the gap between potential innovation and actual implementation in the field.

Conclusions:

The authors suggest that advanced computational integration into safety monitoring remains in early stages. Their synthesis indicates that widespread adoption of rigorous technical standards is currently lacking. Researchers propose that future progress depends on aligning studies with established best practices. The review highlights that while traditional statistics dominate, deep learning is gaining traction. The team notes that data ingestion processes frequently miss opportunities for modern algorithmic optimization. They conclude that current trends show a slow but positive shift toward sophisticated modeling. The evidence implies that consistent methodological quality is necessary for meaningful improvements. The study provides a framework for evaluating future developments in this evolving field.

The researchers propose that while traditional statistical methods remain dominant, there is a growing trend toward using deep learning. This shift indicates a gradual transition toward more sophisticated computational approaches in drug safety monitoring.

The authors identify off-the-shelf techniques as a common tool, noting that sixty-one percent of studies utilizing modern methods rely on these pre-existing models with only minor adjustments.

The researchers indicate that adherence to rigorous best practices is necessary for valid results, noting that only ten percent of the total papers reviewed met these high standards.

The authors highlight that data intake and ingestion represent a critical area, where only nineteen percent of the one hundred fifty-four papers focusing on this task incorporated current best practices.

The team measured the adoption of modern algorithms by comparing the prevalence of traditional statistical methods against newer deep learning models across the identified literature.

The researchers propose that although advanced technology has not yet fully transformed the field, recent evidence suggests a potential shift toward greater integration of these tools.